Accuray Future Growth
Future criteria checks 4/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Accuray.
Key information
120.7%
Earnings growth rate
120.3%
EPS growth rate
Medical Equipment earnings growth | 18.1% |
Revenue growth rate | 5.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 28 Apr 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2025 | 505 | 27 | N/A | N/A | 2 |
6/30/2024 | 479 | 9 | N/A | N/A | 5 |
6/30/2023 | 451 | -4 | N/A | N/A | 5 |
3/31/2020 | 405 | 3 | -15 | -11 | N/A |
12/31/2019 | 409 | -1 | -11 | -6 | N/A |
9/30/2019 | 413 | -17 | -40 | -36 | N/A |
6/30/2019 | 419 | -16 | -34 | -30 | N/A |
3/31/2019 | 415 | -16 | -16 | -11 | N/A |
12/31/2018 | 412 | -24 | -6 | 0 | N/A |
9/30/2018 | 410 | -24 | 6 | 14 | N/A |
6/30/2018 | 405 | -24 | 12 | 18 | N/A |
3/31/2018 | 403 | -28 | 7 | 14 | N/A |
12/31/2017 | 401 | -24 | -7 | -3 | N/A |
9/30/2017 | 388 | -29 | -12 | -7 | N/A |
6/30/2017 | 383 | -30 | -6 | 0 | N/A |
3/31/2017 | 366 | -32 | -9 | -4 | N/A |
12/31/2016 | 374 | -26 | N/A | 0 | N/A |
9/30/2016 | 396 | -22 | N/A | 12 | N/A |
6/30/2016 | 399 | -26 | N/A | 31 | N/A |
3/31/2016 | 406 | -24 | N/A | 7 | N/A |
12/31/2015 | 398 | -28 | N/A | 17 | N/A |
9/30/2015 | 387 | -32 | N/A | 10 | N/A |
6/30/2015 | 380 | -40 | N/A | -14 | N/A |
3/31/2015 | 380 | -44 | N/A | -13 | N/A |
12/31/2014 | 380 | -46 | N/A | 0 | N/A |
9/30/2014 | 375 | -42 | N/A | -3 | N/A |
6/30/2014 | 369 | -35 | N/A | 0 | N/A |
3/31/2014 | 352 | -44 | N/A | -3 | N/A |
12/31/2013 | 326 | -71 | N/A | -37 | N/A |
9/30/2013 | 310 | -91 | N/A | -64 | N/A |
6/30/2013 | 316 | -97 | N/A | -66 | N/A |
3/31/2013 | 332 | -99 | N/A | -67 | N/A |
12/31/2012 | 363 | -82 | N/A | -42 | N/A |
9/30/2012 | 392 | -67 | N/A | -2 | N/A |
6/30/2012 | 409 | -71 | N/A | -38 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: XEJ is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.2%).
Earnings vs Market: XEJ is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: XEJ is expected to become profitable in the next 3 years.
Revenue vs Market: XEJ's revenue (5.9% per year) is forecast to grow faster than the German market (4.3% per year).
High Growth Revenue: XEJ's revenue (5.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if XEJ's Return on Equity is forecast to be high in 3 years time